IDH2 and glioma: On the other hand, Deep learning from histoPathoLOgy and methYlation (DEPLOY), a deep learning model classifying CNS tumors, was trained to predict tumor types including IDH mutant gliomas from hematoxylin and eosin (H&E) sections, (Hoang et al., 2024).